
Gossamer Bio Investor Relations Material
Latest events

Q1 2025
Gossamer Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Gossamer Bio Inc
Access all reports
Gossamer Bio, Inc. is a U.S.-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in immunology, inflammation, and oncology. The company’s research pipeline targets diseases with unmet medical needs, including autoimmune disorders, inflammatory conditions, and cancer. Gossamer Bio leverages its scientific expertise to advance novel drug candidates through clinical trials, aiming to deliver effective treatment options for complex and chronic illnesses. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
GOSS
Country
🇺🇸 United States